0% found this document useful (0 votes)
48 views

Ashmun Nisha, M.Pharm Thesis, 2019

The document provides a comprehensive literature review on the topic of schizophrenia, discussing its history, classification, symptoms, potential causes such as genetics and environment, treatment options, and more. Numerous scholarly articles and medical sources are referenced throughout the extensive review of the subject.

Uploaded by

NATIONAL XEROX
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
48 views

Ashmun Nisha, M.Pharm Thesis, 2019

The document provides a comprehensive literature review on the topic of schizophrenia, discussing its history, classification, symptoms, potential causes such as genetics and environment, treatment options, and more. Numerous scholarly articles and medical sources are referenced throughout the extensive review of the subject.

Uploaded by

NATIONAL XEROX
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 6

Chapter 7

Al-Snafi, A. E. (2013). The pharmacology of Bacopa monniera. A review, Int J Pharma Sci
Res, 4, 154-159.
Al-Snafi, A. E. (2017). A review on Dodonaea viscosa: A potential medicinal plant. IOSR
Journal of Pharmacy, 7(2), 10-21.
Barry SJ, Gaughan TM, Hunter R (June 2012). "Schizophrenia". BMJ Clinical
Evidence. 2012

Berrios GE, Luque R, Villagran J (2003). "Schizophrenia: a conceptual


history" (PDF). International Journal of Psychology and Psychological Therapy. 3 (2): 111–
140. Archived (PDF) from the original on 30 March 2012

Bhattacharya, S. K., & Ghosal, S. (1998). Anxiolytic activity of a standardized extract of


Bacopa monniera: an experimental study. Phytomedicine, 5(2), 77-82.
Brown AS (January 2011). "The environment and susceptibility to schizophrenia". Progress
in Neurobiology. 93 (1): 23–58

Broyd A, Balzan RP, Woodward TS, Allen P (June 2017). "Dopamine, cognitive biases and
assessment of certainty: A neurocognitive model of delusions". Clinical Psychology
Review. 54: 96–106

Buckley PF, Miller BJ, Lehrer DS, Castle DJ (March 2009). "Psychiatric comorbidities and
schizophrenia". Schizophrenia Bulletin. 35 (2): 383–402

Camill, P., McKone, M. J., Sturges, S. T., Severud, W. J., Ellis, E., Limmer, J., ... &
Talukder, S. (2004). Community‐and ecosystem‐level changes in a species‐rich tallgrass
prairie restoration. Ecological applications, 14(6), 1680-1694.
Campos, A. C., Fogaca, M. V., Aguiar, D. C., & Guimaraes, F. S. (2013). Animal models of
anxiety disorders and stress. Brazilian Journal of Psychiatry, 35, S101-S111.

Cannon TD, Cornblatt B, McGorry P (May 2007). "The empirical status of the ultra high-risk
(prodromal) research paradigm". Schizophrenia Bulletin. 33 (3): 661–4

Catts VS, Lai YL, Weickert CS, Weickert TW, Catts SV (April 2016). "A quantitative
review of the post-mortem evidence for decreased cortical N-methyl-D-aspartate receptor
expression levels in schizophrenia: How can we link molecular abnormalities to mismatch
negativity deficits?". Biological Psychology. 116: 57–67

Chakravarthi, K. K., & Avadhani, R. (2013). Beneficial effect of aqueous root extract of
Glycyrrhiza glabra on learning and memory using different behavioral models: An
experimental study. Journal of natural science, biology, and medicine, 4(2), 420.

Ashmun Nisha, M.Pharm Thesis, 2019 Page 33


Chapter 7

Channa, S., Dar, A., Anjum, S., & Yaqoob, M. (2006). Anti-inflammatory activity of Bacopa
monniera in rodents. Journal of ethnopharmacology, 104(1-2), 286-289.
Combs DR, Mueser KT, Gutierrez MM (2011). "Chapter 8: Schizophrenia: Etiological
considerations". In Hersen M, Beidel DC (eds.). Adult psychopathology and diagnosis (6th
ed.). John Wiley & Sons

Craddock N, Owen MJ (February 2010). "The Kraepelinian dichotomy - going, going... but
still not gone". The British Journal of Psychiatry. 196 (2): 92–5

Davis, P. M. (2011). Open access, readership, citations: a randomized controlled trial of


scientific journal publishing. The FASEB Journal, 25(7), 2129-2134.
Dhanasekaran, M., Tharakan, B., Holcomb, L. A., Hitt, A. R., Young, K. A., & Manyam, B.
V. (2007). Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa
monniera. Phytotherapy Research, 21(10), 965-969.

Dvir Y, Denietolis B, Frazier JA (October 2013). "Childhood trauma and psychosis". Child
and Adolescent Psychiatric Clinics of North America. 22 (4): 629–41

Fusar-Poli P, Meyer-Lindenberg A (January 2013). "Striatal presynaptic dopamine in


schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies". Schizophrenia
Bulletin. 39 (1): 33–42

Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV (June 2004).
"Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive
dysfunction". Psychopharmacology. 174 (1): 3–16

Gregg L, Barrowclough C, Haddock G (May 2007). "Reasons for increased substance use in
psychosis". Clinical Psychology Review. 27 (4): 494–510

Haider, S., Khaliq, S., & Haleem, D. J. (2007). Enhanced serotonergic neurotransmission in
the hippocampus following tryptophan administration improves learning acquisition and
memory consolidation in rats. Pharmacological reports, 59(1), 53.
Heinrichs RW (2003). "Historical origins of schizophrenia: two early madmen and their
illness". Journal of the History of the Behavioral Sciences. 39 (4): 349–63

Izquierdo, L. A., Schröder, N., Ardenghi, P., Quevedo, J., Netto, C. A., Medina, J. H., &
Izquierdo, I. (1997). Systemic administration of ACTH or vasopressin reverses the amnestic
effect of posttraining β-endorphin or electroconvulsive shock but not that of
intrahippocampal infusion of protein kinase inhibitors. Neurobiology of learning and
memory, 68(2), 197-202.

Ashmun Nisha, M.Pharm Thesis, 2019 Page 34


Chapter 7

Jadiya, P., Khan, A., Sammi, S. R., Kaur, S., Mir, S. S., & Nazir, A. (2011). Anti-
Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological
Caenorhabditis elegans models of Parkinson’s disease. Biochemical and biophysical research
communications, 413(4), 605-610.

Kane JM, Correll CU (2010). "Pharmacologic treatment of schizophrenia". Dialogues in


Clinical Neuroscience. 12 (3): 345–57

Kaur, H., Singh, D., Singh, B., & Goel, R. K. (2010). Anti-amnesic effect of Ficus religiosa
in scopolamine-induced anterograde and retrograde amnesia. Pharmaceutical biology, 48(2),
234-240.

Khandaker GM (August 2012). "Childhood infection and adult schizophrenia: a meta-


analysis of population-based studies". Schizophr. Res. 139 (1–3): 161–8

Kishore, K., & Singh, M. (2005). Effect of bacosides, alcoholic extract of Bacopa monniera
Linn.(brahmi), on experimental amnesia in mice.
Kumar, A., Shukla, R., Singh, P., & Dubey, N. K. (2010). Chemical composition, antifungal
and antiaflatoxigenic activities of Ocimum sanctum L. essential oil and its safety assessment
as plant based antimicrobial. Food and Chemical Toxicology, 48(2), 539-543.

Lachance LR, McKenzie K (February 2014). "Biomarkers of gluten sensitivity in patients


with non-affective psychosis: a meta-analysis". Schizophrenia Research (Review). 152 (2–3):
521–7

Lefas, I. (2018). The intriguing role of the Gut Microbiome in the etiology and pathogenesis
of Neuropsychiatric Disorders. Dialogues in Clinical Neuroscience & Mental Health, 1(2).

Lowther C, Costain G, Baribeau DA, Bassett AS (September 2017). "Genomic Disorders in


Psychiatry-What Does the Clinician Need to Know?". Current Psychiatry Reports. 19 (11):
82

Luchsinger, J. A., Tang, M. X., Shea, S., & Mayeux, R. (2004). Hyperinsulinemia and risk of
Alzheimer disease. Neurology, 63(7), 1187-1192.
Marshall M, Rathbone J (June 2011). "Early intervention for psychosis". The Cochrane
Database of Systematic Reviews (6): CD004718

Mayo Clinic, "Schizoaffective Disorder —Definition" January 25, 2014

Medical News Today, "What Are the Different Types of Schizophrenia? How Many
Subtypes of Schizophrenia Are There?" September 17, 2014

Ashmun Nisha, M.Pharm Thesis, 2019 Page 35


Chapter 7

Medical News Today, "What Is Disorganized Schizophrenia (hebeprenia)? What Causes


Disorganized Schizophrenia?" September 15, 2014

Mondal, S., Varma, S., Bamola, V. D., Naik, S. N., Mirdha, B. R., Padhi, M. M., ... &
Mahapatra, S. C. (2011). Double-blinded randomized controlled trial for immunomodulatory
effects of Tulsi (Ocimum sanctum Linn.) leaf extract on healthy volunteers. Journal of
ethnopharmacology, 136(3), 452-456.

Murayama, H., Tanaka, E., & Toyama, H. (1985). Statistical noise with the weighted
backprojection method for single photon emission computed tomography. Kaku Igaku, 22(3),
307-319.

Negrón-Oyarzo I, Lara-Vásquez A, Palacios-García I, Fuentealba P, Aboitiz F (March


2016). "Schizophrenia and reelin: a model based on prenatal stress to study epigenetics, brain
development and behavior". Biological Research. 49: 16

Nemani K, Hosseini Ghomi R, McCormick B, Fan X (January 2015). "Schizophrenia and the
gut-brain axis". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 56: 155–
60

Noll R (2011). American madness: the rise and fall of dementia praecox. Cambridge, MA:
Harvard University Press

Noll R (2012). "Whole body madness". Psychiatric Times. 29 (12): 13–14. Archived from
the original on 11 January 2013

Nordgaard J, Arnfred SM, Handest P, Parnas J (January 2008). "The diagnostic status of
first-rank symptoms". Schizophrenia Bulletin. 34 (1): 137–54

O'Donovan MC, Williams NM, Owen MJ (October 2003). "Recent advances in the genetics
of schizophrenia". Human Molecular Genetics. 12 Spec No 2: R125–33

Owen MJ, Sawa A, Mortensen PB (July 2016). "Schizophrenia". Lancet. 388 (10039): 86–97

Parakh P, Basu D (August 2013). "Cannabis and psychosis: have we found the missing
links?". Asian Journal of Psychiatry (Review). 6 (4): 281–7

Parakh P, Basu D (August 2013). "Cannabis and psychosis: have we found the missing
links?". Asian Journal of Psychiatry (Review). 6 (4): 281–7

Picchioni MM, Murray RM (July 2007). "Schizophrenia". BMJ. 335 (7610): 91–5

Picchioni MM, Murray RM (July 2007). "Schizophrenia". BMJ. 335 (7610): 91–5

PsychCentral, "Types of Schizophrenia"

Ashmun Nisha, M.Pharm Thesis, 2019 Page 36


Chapter 7

Rahnama, S., Rabiei, Z., Alibabaei, Z., Mokhtari, S., Rafieian-kopaei, M., & Deris, F.
(2015). Anti-amnesic activity of Citrus aurantium flowers extract against scopolamine-
induced memory impairments in rats. Neurological Sciences, 36(4), 553-560.
Rajani, M. (2004). Ramawat, KG, ed. Biotechnology of Medicinal Plants: Vitalizer and
Therapeutic. Enfield, NH: Science Publishers.
Reddy, K. N., & Murty, O. P. (2014). The essentials of forensic medicine and
toxicology (Vol. 2010, pp. 296-297). New Delhi: Jaypee Brothers Medical Publishers.

Schizophrenic.com, "Undifferentiated Schizophrenic"

Schmitt, N., Cobb, T., Horst, M., & Schmitt, D. (2017). How much vocabulary is needed to
use English? Replication of van Zeeland & Schmitt (2012), Nation (2006) and Cobb
(2007). Language Teaching, 50(2), 212-226.

Schneider K (1959). Clinical Psychopathology (5 ed.). New York: Grune & Stratton

Schultz SH, North SW, Shields CG (June 2007). "Schizophrenia: a review". American
Family Physician. 75 (12): 1821–9

Seeman MV, Seeman P (January 2014). "Is schizophrenia a dopamine supersensitivity


psychotic reaction?". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 48:
155–60

Smith T, Weston C, Lieberman J (August 2010). "Schizophrenia (maintenance


treatment)". American Family Physician. 82 (4): 338–9

Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T (January 2013). "Early
interventions to prevent psychosis: systematic review and meta-analysis". BMJ. 346: f185

Subhan, F., Abbas, M., Rauf, K., & Baseer, A. (2010). Anti GIT motility, toxicological and
phytochemical studies on Bacopa monnieri. Pharmacologyonline, 3, 937-950.
Tandon R, Keshavan MS, Nasrallah HA (March 2008). "Schizophrenia, "Just the Facts":
what we know in 2008 part 1: overview". Schizophrenia Research. 100 (1–3): 4–19

Taylor DM, Duncan-McConnell D (2000). "Refractory schizophrenia and atypical


antipsychotics". Journal of Psychopharmacology. 14 (4): 409–18

Thompson, W. F., Graham, P., & Russo, F. A. (2005). Seeing music performance: Visual
influences on perception and experience. Semiotica, 2005(156), 203-227.

Ashmun Nisha, M.Pharm Thesis, 2019 Page 37


Chapter 7

Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., & Telser, J. (2007). Free
radicals and antioxidants in normal physiological functions and human disease. The
international journal of biochemistry & cell biology, 39(1), 44-84.

van Os J, Kapur S (August 2009). "Schizophrenia" (PDF). Lancet. 374 (9690): 635–45

WebMD, "Understanding Bipolar Disorder: Symptoms"

WebMD, "What Is Schizoaffective Disorder?"

WHO, (2015). "Psychosis and schizophrenia in adults: treatment and


management" (PDF). NICE. March 2014. p. 7. Archived from the original (PDF) on 20 April
2014. Retrieved 19 April 2014

Yolken R (June 2004). "Viruses and schizophrenia: a focus on herpes simplex


virus". Herpes. 11 Suppl 2 (Suppl 2): 83A–88A

Yuhas D. "Throughout History, Defining Schizophrenia Has Remained a Challenge".


Scientific American Mind (March/April 2013). Archivedfrom the original on 5 November
2013. Retrieved 3 March 2013

Zhou, Y., Shen, Y. H., Zhang, C., Su, J., Liu, R. H., & Zhang, W. D. (2007). Triterpene
saponins from Bacopa monnieri and their antidepressant effects in two mice models. Journal
of natural products, 70(4), 652-655.

Ashmun Nisha, M.Pharm Thesis, 2019 Page 38

You might also like